Julia Edwards serves as the Vice President at Genentech, where she leads a global organization dedicated to regulatory submissions that are crucial for the biologics drug development lifecycle. With over 23 years of extensive experience in global biopharmaceutical Chemistry, Manufacturing, and Controls (CMC), Julia has...
Julia Edwards serves as the Vice President at Genentech, where she leads a global organization dedicated to regulatory submissions that are crucial for the biologics drug development lifecycle. With over 23 years of extensive experience in global biopharmaceutical Chemistry, Manufacturing, and Controls (CMC), Julia has established herself as a regulatory expert, adept at navigating the complexities of drug development from early phases through to initial marketing authorizations and successful product launches. Her strategic vision and deep understanding of regulatory frameworks enable her to effectively guide cross-functional teams, ensuring compliance with U.S. Food and Drug Administration (FDA) regulations and other global standards.
In her role, Julia oversees key projects that involve the validation and technology transfer of innovative biologics, driving initiatives that enhance market access and streamline regulatory submissions. Her leadership is characterized by a strong emphasis on talent development, having cultivated high-performing teams for over 15 years. Julia’s management style fosters collaboration and empowers her teams to excel in a fast-paced environment, ultimately contributing to the successful advancement of Genentech’s pipeline.
Julia’s academic credentials, including an MBA from the Wharton School of Business, complement her technical expertise, allowing her to approach challenges with a business-oriented mindset. Her ability to align regulatory strategies with broader business objectives positions her as a pivotal figure in the organization, driving not only compliance but also the strategic growth of Genentech’s portfolio in the competitive biopharmaceutical landscape.
